Pituitary Phenotypes of Mice Lacking the Notch Signalling Ligand Delta-Like 1 Homologue

Journal of Neuroendocrinology

Volumn 25, Issue 4, 2013, Pages 391-401

  Cheung, L Y M ^a   Rizzoti, K ^a   Lovell Badge, R ^a   Le Tissier, P R ^a,b  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Dlk1; Growth hormone; Pituitary; Pref1

Indexed keywords

CD31 ANTIGEN; CORTICOTROPIN; DELTA LIKE 1 HOMOLOG; FOLLITROPIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE RELEASING HEXAPEPTIDE; HYPOPHYSIS HORMONE; LUTEINIZING HORMONE; NOTCH RECEPTOR; PROLACTIN; PROTEIN; THYROTROPIN; UNCLASSIFIED DRUG;

ADULTHOOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIRTH; BODY HEIGHT; BODY SIZE; BODY WEIGHT; CELL POPULATION; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; EMBRYO DEVELOPMENT; FEMALE; FOLLITROPIN BLOOD LEVEL; GESTATIONAL AGE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HETEROZYGOTE; HOMOZYGOTE; HYPOPHYSIS; HYPOPHYSIS FUNCTION; IN VIVO STUDY; INTRAUTERINE GROWTH RETARDATION; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MOUSE; NONHUMAN; NOTCH SIGNALING PATHWAY; PHENOTYPE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; THYROTROPIN BLOOD LEVEL; WILD TYPE;

ANIMALS; FEMALE; GROWTH; GROWTH HORMONE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PITUITARY GLAND, ANTERIOR; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

EID: 84875489737     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/jne.12010     Document Type: Article

References (46)

1. Brinkmeier ML, Davis SW, Carninci P, MacDonald JW, Kawai J, Ghosh D, Hayashizaki Y, Lyons RH, Camper SA. Discovery of transcriptional regulators and signaling pathways in the developing pituitary gland by bioinformatic and genomic approaches. Genomics 2009; 93: 449-460.
2. Carbajo-Perez E, Watanabe YG. Cellular proliferation in the anterior pituitary of the rat during the postnatal period. Cell Tissue Res 1990; 261: 333-338.
3. Levy A. Physiological implications of pituitary trophic activity. J Endocrinol 2002; 174: 147-155.
4. Lewinski A, Konopacki J, Pawlikowski M, Lewinska MK, Smith NK, Reiter RJ. Effects of intraventricular injections of 6-hydroxydopamine on anterior pituitary cell proliferation. Anat Rec 1984; 208: 421-426.
5. Denef C. Paracrinicity: the story of 30 years of cellular pituitary crosstalk. J Neuroendocrinol 2008; 20: 1-70.
6. Rizzoti K. Adult pituitary progenitors/stem cells: from in vitro characterization to in vivo function. Eur J Neurosci 2010; 32: 2053-2062.
7. Mayo KE, Miller T, De Almeida V, Godfrey P, Zheng J, Cunha SR. Regulation of the pituitary somatotroph cell by GHRH and its receptor. Recent Prog Horm Res 2000; 55: 237-266.
8. Wharton KA, Johansen KM, Xu T, Artavanis-Tsakonas S. Nucleotide sequence from the neurogenic locus notch implies a gene product that shares homology with proteins containing EGF-like repeats. Cell 1985; 2: 567-581.
9. Kopan R, Ilagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 2009; 137: 216-233.
10. Raetzman LT, Ross SA, Cook S, Dunwoodie SL, Camper SA, Thomas PQ. Developmental regulation of Notch signaling genes in the embryonic pituitary: Prop1 deficiency affects Notch2 expression. Dev Biol 2004; 265: 329-340.
11. Zhu X, Zhang J, Tollkuhn J, Ohsawa R, Bresnick EH, Guillemot F, Kageyama R, Rosenfeld MG. Sustained Notch signaling in progenitors is required for sequential emergence of distinct cell lineages during organogenesis. Genes Dev 2006; 20: 2739-2753.
12. Raetzman LT, Cai JX, Camper SA. Hes1 is required for pituitary growth and melanotrope specification. Dev Biol 2007; 304: 455-466.
13. Monahan P, Rybak S, Raetzman LT. The notch target gene HES1 regulates cell cycle inhibitor expression in the developing pituitary. Endocrinology 2009; 150: 4386-4394.
14. Himes AD, Raetzman LT. Premature differentiation and aberrant movement of pituitary cells lacking both Hes1 and Prop1. Dev Biol 2009; 325: 151-161.
15. Raetzman LT, Wheeler BS, Ross SA, Thomas PQ, Camper SA. Persistent expression of Notch2 delays gonadotrope differentiation. Mol Endocrinol 2006; 20: 2898-2908.
16. Takada S, Tevendale M, Baker J, Georgiades P, Campbell E, Freeman T, Johnson MH, Paulsen M, Ferguson-Smith AC. Delta-like and gtl2 are reciprocally expressed, differentially methylated linked imprinted genes on mouse chromosome 12. Curr Biol 2000; 10: 1135-1138.
17. Schmidt JV, Matteson PG, Jones BK, Guan XJ, Tilghman SM. The Dlk1 and Gtl2 genes are linked and reciprocally imprinted. Genes Dev 2000; 14: 1997-2002.
18. Abdallah BM, Ding M, Jensen CH, Ditzel N, Flyvbjerg A, Jensen TG, Dagnaes-Hansen F, Gasser JA, Kassem M. Dlk1/FA1 is a novel endocrine regulator of bone and fat mass and its serum level is modulated by growth hormone. Endocrinology 2007; 148: 3111-3121.
19. Larsen JB, Jensen CH, Schroder HD, Teisner B, Bjerre P, Hagen C. Fetal antigen 1 and growth hormone in pituitary somatotroph cells. Lancet 1996; 347: 191.
20. Tornehave D, Jensen CH, Teisner B, Larsson LI. FA1 immunoreactivity in endocrine tumours and during development of the human fetal pancreas; negative correlation with glucagon expression. Histochem Cell Biol 1996; 106: 535-542.
21. Yevtodiyenko A, Schmidt JV. Dlk1 expression marks developing endothelium and sites of branching morphogenesis in the mouse embryo and placenta. Dev Dyn 2006; 235: 1115-1123.
22. Nakakura T, Sato M, Suzuki M, Hatano O, Takemori H, Taniguchi Y, Minoshima Y, Tanaka S. The spatial and temporal expression of delta-like protein 1 in the rat pituitary gland during development. Histochem Cell Biol 2009; 131: 141-153.
23. Puertas-Avendano RA, Gonzalez-Gomez MJ, Ruvira MD, Ruiz-Hidalgo MJ, Morales-Delgado N, Laborda J, Diaz C, Bello AR. Role of the non-canonical Notch ligand DLK1 in hormone-producing cells of the adult male mouse pituitary. J Neuroendocrinol 2011; 23: 849-859.
24. Chen J, Gremeaux L, Fu Q, Liekens D, VanLaere S, Van Kelecom H. Pituitary progenitor cells tracked down by side population dissection. Stem Cells 2009; 27: 1182-1195.
25. Fauquier T, Rizzoti K, Dattani M, Lovell-Badge R, Robinson IC. SOX2-expressing progenitor cells generate all of the major cell types in the adult mouse pituitary gland. Proc Natl Acad Sci USA 2008; 105: 2907-2912.
26. Ansell PJ, Zhou Y, Schjeide BM, Kerner A, Zhao J, Zhang X, Klibanski A. Regulation of growth hormone expression by Delta-like protein 1 (Dlk1). Mol Cell Endocrinol 2007; 2: 55-63.
27. Altenberger T, Bilban M, Auer M, Knosp E, Wolfsberger S, Gartner W, Mineva I, Zielinski C, Wagner L, Luger A. Identification of DLK1 variants in pituitary- and neuroendocrine tumors. Biochem Biophys Res Commun 2006; 340: 995-1005.
28. Gejman R, Batista DL, Zhong Y, Zhou Y, Zhang X, Swearingen B, Stratakis CA, Hedley-Whyte ET, Klibanski A. Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 2008; 93: 4119-4125.
29. Cheunsuchon P, Zhou Y, Zhang X, Lee H, Chen W, Nakayama Y, Rice KA, Tessa Hedley-Whyte E, Swearingen B, Klibanski A. Silencing of the imprinted DLK1-MEG3 Locus in human clinically nonfunctioning pituitary adenomas. Am J Pathol 2011; 179: 2120-2130.
30. Moon YS, Smas CM, Lee K, Villena JA, Kim KH, Yun EJ, Sul HS. Mice lacking paternally expressed Pref-1/Dlk1 display growth retardation and accelerated adiposity. Mol Cell Biol 2002; 22: 5585-5592.
31. Raghunandan R, Ruiz-Hidalgo M, Jia Y, Ettinger R, Rudikoff E, Riggins P, Farnsworth R, Tesfaye A, Laborda J, Bauer SR. Dlk1 influences differentiation and function of B lymphocytes. Stem Cells Dev 2008; 17: 495-507.
32. Charalambous M, Ferron SR, da Rocha ST, Murray AJ, Rowland T, Ito M, Schuster-Gossler K, Hernandez A, Ferguson-Smith AC. Imprinted gene dosage is critical for the transition to independent life. Cell Metab 2012; 15: 209-221.
33. Sanchez-Cardenas C, Fontanaud P, He Z, Lafont C, Meunier AC, Schaeffer M, Carmignac D, Molino F, Coutry N, Bonnefont X, Gouty-Colomer LA, Gavois E, Hodson DJ, Le Tissier P, Robinson IC, Mollard P. Pituitary growth hormone network responses are sexually dimorphic and regulated by gonadal steroids in adulthood. Proc Natl Acad Sci USA 2010; 107: 21878-21883.
34. Kobayashi S, Wagatsuma H, Ono R, Ichikawa H, Yamazaki M, Tashiro H, Aisaka K, Miyoshi N, Kohda T, Ogura A, Ohki M, Kaneko-Ishino T, Ishino F. Mouse Peg9/Dlk1 and human PEG9/DLK1 are paternally expressed imprinted genes closely located to the maternally expressed imprinted genes: mouse Meg3/Gtl2 and human MEG3. Genes Cells 2000; 5: 1029-1037.
35. Le Tissier PR, Carmignac DF, Lilley S, Sesay AK, Phelps CJ, Houston P, Mathers K, Magoulas C, Ogden D, Robinson IC. Hypothalamic growth hormone-releasing hormone (GHRH) deficiency: targeted ablation of GHRH neurons in mice using a viral ion channel transgene. Mol Endocrinol 2005; 19: 1251-1262.
36. McGuinness L, Magoulas C, Sesay AK, Mathers K, Carmignac D, Manneville JB, Christian H, Phillips JA, Robinson IC IIIrd. Autosomal dominant growth hormone deficiency disrupts secretory vesicles in vitro and in vivo in transgenic mice. Endocrinology 2003; 144: 720-731.
37. Castrique E, Fernandez-Fuente M, LeTissier P, Herman A, Levy A. Use of a prolactin-Cre/ROSA-YFP transgenic mouse provides no evidence for lactotroph transdifferentiation after weaning, or increase in lactotroph/somatotroph proportion in lactation. J Endocrinol 2010; 205: 49-60.
38. Croteau S, Roquis D, Charron MC, Frappier D, Yavin D, Loredo-Osti JC, Hudson TJ, Naumova AK. Increased plasticity of genomic imprinting of Dlk1 in brain is due to genetic and epigenetic factors. Mamm Genome 2005; 16: 127-135.
39. Ferron SR, Charalambous M, Radford E, McEwen K, Wildner H, Hind E, Morante-Redolat JM, Laborda J, Guillemot F, Bauer SR, Farinas I, Ferguson-Smith AC. Postnatal loss of Dlk1 imprinting in stem cells and niche astrocytes regulates neurogenesis. Nature 2011; 475: 381-385.
40. Waite E, Lafont C, Carmignac D, Chauvet N, Coutry N, Christian H, Robinson I, Mollard P, Le Tissier P. Different degrees of somatotroph ablation compromise pituitary growth hormone cell network structure and other pituitary endocrine cell types. Endocrinology 2010; 151: 234-243.
41. Ward RD, Stone BM, Raetzman LT, Camper SA. Cell proliferation and vascularization in mouse models of pituitary hormone deficiency. Mol Endocrinol 2006; 20: 1378-1390.
42. Rossant J, Cross JC. Placental development: lessons from mouse mutants. Nat Rev Genet 2001; 2: 538-548.
43. Woodall SM, Breier BH, Johnston BM, Bassett NS, Barnard R, Gluckman PD. Administration of growth hormone or IGF-I to pregnant rats on a reduced diet throughout pregnancy does not prevent fetal intrauterine growth retardation and elevated blood pressure in adult offspring. J Endocrinol 1999; 163: 69-77.
44. Appelbe OK, Yevtodiyenko A, Muniz-Talavera H, Schmidt JV. Conditional deletions refine the embryonic requirement for Dlk1. Mech Dev 2012; Epub ahead of Print.
45. Garcia A, Alvarez CV, Smith RG, Dieguez C. Regulation of Pit-1 expression by ghrelin and GHRP-6 through the GH secretagogue receptor. Mol Endocrinol 2001; 15: 1484-1495.
46. Goldberg LB, Aujla PK, Raetzman LT. Persistent expression of activated notch inhibits corticotrope and melanotrope differentiation and results in dysfunction of the HPA axis. Dev Biol 2011; 358: 23-32.